TipRanks
Radiopharm Theranostics Limited (AU:RAD)
ASX:RAD
Australian Market
RAD
Radiopharm Theranostics Limited
RESEARCH TOOLSreports
Want to see AU:RAD full AI Analyst Report?

Radiopharm Theranostics Limited (RAD) Ratios

25 Followers

Radiopharm Theranostics Limited Ratios

AU:RAD's free cash flow for Q4 2026 was AU$0.12. For the 2026 fiscal year, AU:RAD's free cash flow was decreased by AU$ and operating cash flow was AU$-28.47. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Jun 24Jun 23
Liquidity Ratios
Current Ratio
 1.16 1.16 2.67 1.30 1.23
Quick Ratio
 1.16 1.16 2.67 1.30 1.23
Cash Ratio
 0.22 0.22 1.95 1.06 0.88
Solvency Ratio
 -1.42 -1.46 -0.78 -1.00 -1.07
Operating Cash Flow Ratio
 -2.79 -2.79 -2.45 -1.31 -1.75
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
AU$ -15.88MAU$ -15.88MAU$ -3.76MAU$ -21.83MAU$ -13.07M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 2.44 2.44 1.93 2.56 1.69
Debt Service Coverage Ratio
 -573.93 -607.38 -486.22 -70.73 -431.47
Interest Coverage Ratio
 -626.93 -607.93 -584.59 -73.43 -468.02
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 0.06 0.06 0.92 0.41 0.32
Profitability Margins
Gross Profit Margin
-39.41%-77.67%73.18%-7121.04%-1027.56%
EBIT Margin
-2545.78%-2468.61%-255.53%-16209.19%-13820.19%
EBITDA Margin
-2496.85%-2468.35%-236.16%-15164.41%-12692.63%
Operating Profit Margin
-2545.78%-2468.61%-284.87%-15777.22%-13781.81%
Pretax Profit Margin
-2219.93%-2055.58%-285.36%-15992.07%-13849.64%
Net Profit Margin
-1992.46%-1992.46%-273.90%-16024.28%-11838.59%
Continuous Operations Profit Margin
-2053.61%-2053.61%-286.13%-16024.28%-11838.59%
Net Income Per EBT
89.75%96.93%95.98%100.20%85.48%
EBT Per EBIT
87.20%83.27%100.17%101.36%100.49%
Return on Assets (ROA)
-91.71%-91.71%-42.44%-66.56%-46.18%
Return on Equity (ROE)
-144.24%-223.39%-81.94%-170.50%-77.98%
Return on Capital Employed (ROCE)
-170.88%-165.70%-53.35%-86.69%-65.28%
Return on Invested Capital (ROIC)
-158.08%-165.54%-53.35%-86.69%-65.28%
Return on Tangible Assets
-251.00%-251.00%-91.97%-208.94%-210.94%
Earnings Yield
-195.68%-81.90%-80.00%-326.51%-114.12%
Efficiency Ratios
Receivables Turnover
 0.16 0.16 1.29 0.30 0.07
Payables Turnover
 0.71 0.90 0.57 3.36 1.12
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 59.99 59.99 250.63 4.92 4.28
Asset Turnover
 0.05 0.05 0.15 <0.01 <0.01
Working Capital Turnover Ratio
 0.16 0.20 0.89 0.07 0.03
Cash Conversion Cycle
 1.78K 1.90K -361.33 1.10K 5.25K
Days of Sales Outstanding
 2.30K 2.30K 283.28 1.20K 5.58K
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 517.07 405.72 644.60 108.69 327.35
Operating Cycle
 2.30K 2.30K 283.28 1.20K 5.58K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.01 -0.01 -0.02 -0.06 -0.07
Free Cash Flow Per Share
 >-0.01 0.00 -0.02 -0.06 -0.08
CapEx Per Share
 <0.01 0.01 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.43 0.00 1.00 1.00 1.07
Dividend Paid and CapEx Coverage Ratio
 -1.75 -1.00 0.00 -4.60M -15.16
Capital Expenditure Coverage Ratio
 -1.75 -1.00 0.00 -4.60M -15.16
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
 -19.07 -19.07 -2.73 -76.78 -79.36
Free Cash Flow Yield
-119.84%0.00%-79.87%-156.45%-81.55%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.51 -1.22 -1.25 -0.31 -0.88
Price-to-Sales (P/S) Ratio
 6.84 24.33 3.42 49.08 103.74
Price-to-Book (P/B) Ratio
 1.14 2.73 1.02 0.52 0.68
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.83 0.00 -1.25 -0.64 -1.23
Price-to-Operating Cash Flow Ratio
 -0.53 -1.28 -1.25 -0.64 -1.31
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 0.11 0.01 -0.03 0.00
Price-to-Fair Value
 1.14 2.73 1.02 0.52 0.68
Enterprise Value Multiple
 -0.21 -0.93 -0.53 0.09 -0.50
Enterprise Value
 14.78M 63.20M 16.76M -3.89M 18.63M
EV to EBITDA
 -0.21 -0.93 -0.53 0.09 -0.50
EV to Sales
 5.34 22.83 1.25 -13.00 63.72
EV to Free Cash Flow
 -0.65 0.00 -0.46 0.17 -0.75
EV to Operating Cash Flow
 -0.28 -1.20 -0.46 0.17 -0.80
Tangible Book Value Per Share
 <0.01 <0.01 >-0.01 -0.06 -0.04
Shareholders’ Equity Per Share
 <0.01 <0.01 0.02 0.07 0.14
Tax and Other Ratios
Effective Tax Rate
 0.07 <0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
 -0.02 -0.02 -0.02 -0.12 -0.11
Tax Burden
 0.90 0.97 0.96 1.00 0.85
Interest Burden
 0.87 0.83 1.12 0.99 1.00
Research & Development to Revenue
 19.21 18.05 2.05 58.68 75.34
SG&A to Revenue
 5.86 5.86 1.23 43.58 44.54
Stock-Based Compensation to Revenue
 0.00 0.00 0.14 8.82 10.39
Income Quality
 0.96 0.96 1.00 0.48 0.67
Currency in AUD